Scientists at McMaster University have discovered several new biomarkers from a single drop of blood that could allow earlier and more definitive detection of cystic fibrosis (CF), a genetic disease which strikes both children and adults, causing chronic problems with the digestive system and the lungs.
The findings, published online in the Journal of Proteome Research, are significant because current newborn screening methods are not accurate enough to identify the disorder in the population, which can manifest itself in many different ways, requiring additional testing and causing further stress for anxious parents.
“The earlier CF is detected, the earlier it can be managed and treated, which means better health outcomes for affected infants, including their future growth and development,” says Philip Britz-McKibbin, lead author of the study and a professor in McMaster’s Department of Chemistry & Chemical Biology, who conducted the research with graduate student Alicia DiBattista, now a postdoctoral fellow at Newborn Screening Ontario (NSO).
A tiny amount of blood is drawn from the heel of all babies as part of universal newborn screening programs that test for many rare yet treatable diseases since babies usually have no signs of disease at birth, including CF.
In the case of CF, infants are screened for a pancreatic enzyme and then a panel of disease-causing genetic mutations associated with CF. However, further testing to confirm or rule out the disease finds that most babies who screen-positive do not actually have the disease. These babies are later found to be “healthy carriers” or their results are deemed to be “false positives”.
With this in mind, researchers set out to determine whether they could discover chemical signatures in a dried blood spot that could better distinguish infants who have CF from those who do not.
Using less than a single drop of blood stored at NSO at CHEO, a pediatric health and research centre in Ottawa, researchers analyzed and compared samples from infants confirmed to have CF with the samples of both healthy and screen positive infants. They found several new compounds as well as simple amino acids directly related to affected infants with CF who otherwise have no symptoms and normal birth weight.
“These biomarkers provide new insights into the disease process early in life before symptoms are fully apparent,” says Britz-McKibbin. “Moreover, these compounds can be analyzed by mass spectrometry at incremental costs since it is already used for testing many other genetic diseases at newborn screening facilities around the world”
“Ontario started screening for Cystic Fibrosis in April 2007, and since that time over 400 children have already benefited from early recognition and early treatment. But for every one of these children, about 10 have had a false-positive result. We want to get this number down and are very hopeful that the new biomarkers discovered by this research project will help us do exactly that,” says Pranesh Chakraborty, medical director of NSO at CHEO.
In Canada, life expectancy rates have risen dramatically with the median age of survival now over 50 years, due to better treatments to improve lung function, better nutrition, lung transplants. The advent of universal newborn screening programs for CF will likely further improve the quality of life of affected patients.
“We know that early detection can have significant benefits for people living with cystic fibrosis,” said Dr. John Wallenburg, chief scientific officer at Cystic Fibrosis Canada. “The current screening methodologies capture a broad swathe of families that then need further testing to narrow down those that are true positives. The anxiety and distress that such further testing can needlessly cause families was a major concern that slowed the adoption of newborn screening in some jurisdictions. Dr. Britz-McKibbin’s data provide insights for more specific newborn screening, as well as early manifestations of the disease.”
The Latest on: Cystic fibrosis
via Google News
The Latest on: Cystic fibrosis
- Dudley schoolboy with cystic fibrosis denied chance to go to school for more than seven months on May 16, 2019 at 9:30 pm
Logan Shaw has a life-limiting genetic condition and will be lucky to see his 20th birthday. The seven-year-old’s time is precious - but for the last seven months he has been unable to go to school. ... […]
- Theresa May urges US makers of cystic fibrosis drug to strike ‘crucial’ deal with NHS on May 16, 2019 at 4:03 pm
Her call came as Zoey Jones and her one-year-old daughter Eve, pictured, who has CF, went to Downing Street with other campaigners yesterday to plead for the Prime Minister’s help. The US drug company ... […]
- Row over vital cystic fibrosis drug sparks protest on May 16, 2019 at 12:48 pm
The mother of a baby girl with cystic fibrosis today delivered 65 roses to Downing Street to protest at the failure of the NHS to provide a potentially life-changing drug. It is exactly one year since ... […]
- Cystic fibrosis scandal: Little Eve makes 65 roses in plea for life-saving drugs on May 16, 2019 at 10:02 am
A year ago today, Mrs May told MPs she wanted a "speedy resolution" to a drugs deal between US firm Vertex, which makes Orkambi, and NHS England. The term "65 roses" was coined in the 1960s when a CF ... […]
- Cystic fibrosis ambassador Jackie Fraser in Geraldton raising awareness for Cystic Fibrosis Awareness Month in May. on May 16, 2019 at 9:06 am
Cystic fibrosis ambassador Jackie Fraser, walking along a beach in Geraldton, is raising awareness about the condition as she travels the country. ... […]
- Mum delivers 65 roses to Downing Street in bid to speed up NHS availability of vital cystic fibrosis drugs on May 16, 2019 at 5:58 am
Calls for NHS access to potentially life-saving drugs are growing, one year to the day after Theresa May said she wants a “speedy resolution” for cystic fibrosis sufferers. A young mum handed in a ... […]
- 'There's no reason a child born with cystic fibrosis today can't go on to live a full life' on May 15, 2019 at 1:22 pm
When Jackie Fraser was born with cystic fibrosis, doctors told her parents she would likely live to the age of 27. Ms Fraser turned 27 this year. But the bright-eyed newlywed said she refused to let ... […]
- Global cystic fibrosis market is expected to grow with a CAGR of 16.6% over the forecast period from 2019-2025 on May 14, 2019 at 3:30 pm
NEW YORK, May 14, 2019 /PRNewswire/ -- The report on the global cystic fibrosis (CF) market provides qualitative and quantitative analysis for the period from 2017 to 2025. Read the full report: https ... […]
- Hundreds walk in Cedar Falls to benefit cystic fibrosis (PHOTOS) on May 11, 2019 at 11:30 am
CEDAR FALLS -- Hundreds of people walked to help cure cystic fibrosis Saturday morning. The Great Strides Walk is a nationwide effort to raise funds to find a cure for cystic fibrosis, a genetic ... […]
- Cystic Fibrosis Therapeutics Market Demand & Future Scope Including Top Key Players on May 10, 2019 at 1:35 am
May 10, 2019 (WiredRelease via COMTEX) -- Cystic fibrosis is an inherited disorder, a mutation in a gene changes a protein that regulates the movement of salts in and out of cells. It causes several ... […]
via Bing News